Biotech investor activism is gaining momentum, signaling a shift in the industry’s dynamics. With a focus on influencing decisions related to drug development, business strategies, and financial performance, investors are increasingly vocal in shaping the direction of biotech companies. This trend reflects the growing influence of financial stakeholders in driving innovation and maximizing returns in […]